IXICO plc (AIM:IXI)

London · Delayed Price · Currency is GBP · Price in GBX

8.53

-0.23 (-2.57%)

Jun 16, 2026, 11:02 AM GMT

-24.22% (1Y)

Market Cap	19.08M +83.0%
Revenue (ttm)	7.28M +13.0%
Net Income	-1.82M
EPS	-0.02
Shares Out	218.05M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	52,634
Open	8.50
Previous Close	8.75
Day's Range	8.50 - 8.53
52-Week Range	6.26 - 15.00
Beta	0.13
Analysts	Strong Buy
Price Target	26.00 (+204.99%)
Earnings Date	May 19, 2026

About IXICO

IXICO plc provides data analytics services to biopharmaceutical industry in the United States, the United Kingdom, the Netherlands, Denmark, Switzerland, Ireland, Europe, and internationally. The company offers collection, analysis, management, and reporting on gathered clinical study data; neurological diseases data collection and analysis; and sales and marketing services. It also provides imaging contract research organization solutions, including imaging biomarkers, such as radiological reads, volumetric MRI, PET and SPECT, and advanced MRI... [Read more]

Industry Biotechnology

Sector Healthcare

Founded 1995

Employees 79

Stock Exchange London Stock Exchange AIM

Ticker Symbol IXI

Full Company Profile

Financial Performance

In fiscal year 2025, IXICO's revenue was 6.53 million, an increase of 13.32% compared to the previous year's 5.77 million. Losses were -1.65 million, -17.49% less than in 2024.

Financial Statements